Linking bioprospecting with sustainable development and conservation: The Panama case

Biodiversity and Conservation

Volumn 16, Issue 10, 2007, Pages 2789-2800

  Kursar, Thomas A ^a   Caballero George, Catherina C ^b   Capson, Todd L ^b   Cubilla Rios, Luis ^c   Gerwick, William H ^b,d   Heller, Maria V ^b,g   Ibañez, Alicia ^b   Linington, Roger G ^d,e   McPhail, Kerry L ^f   Ortega Barría, Eduardo ^e   Romero, Luz I ^e   Coley, P D ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b SMITHSONIAN TROPICAL RESEARCH INSTITUTE   (Panama)

^c UNIVERSIDAD DE PANAMÁ   (Panama)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Institute of Advanced Scientific Research and High Technology   (Panama)

^f OREGON STATE UNIVERSITY   (United States)

^g Tecnología e innovación   (Panama)

Author keywords

Bioprospecting; Chagas' disease; Convention on biological diversity; Ecosystem services; ICBG; Leishmaniasis; Malaria; Panama; Policy makers; Sustainable development

Indexed keywords

BIODIVERSITY; ECOSYSTEM SERVICE; LEISHMANIASIS; MALARIA; POLICY MAKING; SUSTAINABLE DEVELOPMENT;

CENTRAL AMERICA; PANAMA [CENTRAL AMERICA];

EID: 34548388419     PISSN: 09603115     EISSN: 15729710     Source Type: Journal    
DOI: 10.1007/s10531-007-9214-2     Document Type: Article

References (77)

1. Agnew B (2000) When pharma merges, R & D is the dowry. Science 287:1952-1953
2. Aide TM, Grau HR (2004) Globalization, migration and Latin American ecosystems. Science 305:1915-1916
3. Aldhous P (1991) 'Hunting licence' for drugs. Nature 353:290
4. Angell M (2004) The truth about the drug companies. New York Rev Books 51 July 15:52-58
5. Annan K (2003) A challenge to the world scientists. Science 299:1485
6. Beattie A, Barthlott W, Elisabetsky E et al (2005) Chapter 10. New products and industries from biodiversity. In: Hassan R, Scholes R, Ash N (eds). Millennium ecosystem assessment, ecosystems and human well-being, vol 1. Island Press, Washington, D. C
7. Capson TL, Coley PD, Kursar TA (1996) A new paradigm for drug discovery in tropical rainforests. Nat Biotechnol 14:1200-1202
8. CBD (2003) Convention on Biological Diversity. Access to genetic resources and benefit-sharing case studies. www.biodiv.org/programmes/socio-eco/ benefit/cs.aspx. Cited 18 April 2007
9. CGIAR (2007) Consultative Group on International Agricultural Research http://www.cgiar.org Cited 18 April 2007
10. Coley PD, Heller MV, Aizprua R et al (2003) Use of ecological criteria in designing plant collection strategies for drug discovery. Front Ecol Environ 1:421-428
11. Corbett Y, Herrera L, Gonzalez J et al (2004) A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. Am J Trop Med Hyg 70:119-124
12. Correa JE, Ríos CH, Castillo AR et al (2006) Minor alkaloids from Guatteria dumetorum with antileishmanial activity. Planta Med 72:270-272
13. Daily GC, Ellison K (2002) The new economy of nature: the quest to make conservation profitable. Island Press, Washington, D.C
14. Defries RS, Bounoua L, Collatz GJ (2002) Human modification of the landscape and surface climate in the next fifty years. Global Change Biol 8:438-458
15. Gelb MH, Hol WGJ (2002) Drugs to combat tropical protozoan parasites. Science 297:343-344
16. Gollin MA (1993) The convention on biological diversity and intellectual property rights. In: Reid WV, Laird SA, Meyer CA et al (eds) Biodiversity prospecting: using genetic resources for sustainable development. World Resources Institute, Washington, D.C
17. Gollin MA (1999) New rules for natural products research. Nat Biotechnol 17:921-923
18. Grifo F, Newman DJ (1997) The origins of prescription drugs. In: Grifo F, Rosenthal J (eds) Biodiversity and human health. Island Press, Washington, D.C
19. Grifo F, Rosenthal J (1997) Biodiversity and human health. Island Press, Washington, D.C
20. Gutiérrez M, Capson T, Guzmán HM et al (2004) L-galactose as a natural product: isolation from a marine octocoral of the first α-L-galactosyl saponin. Tetrahedron Lett 45:7833-7836
21. Gutiérrez M, Capson TL, Guzmán HM et al (2005a) Antiprotozoal activity against Plasmodium falciparum and Trypanosoma cruzi of aeroplysinin-1 isolated from the new sponge Aplysina chiriquensis. Pharm Biol 43:762-765
22. Gutiérrez M, Capson TL, Guzmán HM et al (2005b) Leptolide, a new furanocembranolide diterpene from Leptogorgia alba. J Nat Prod 68:614-616
23. Holmgren M, Schnitzer SA (2004) Science on the rise in developing countries. PLoS Biol 2:10-13
24. Horwitz SB (1992) Mechanisms of action of taxol. Trends Pharmacol Sci 13:134-136
25. Hussein AA, Bozzi B, Correa M et al (2003a) Bioactive constituents from three Vismia species. J Nat Prod 66:858-860
26. Hussein AA, Gomez B, Ramos M et al (2003b) Constituents of Hirea reclinata and their anti-HIV activity. Rev Latinoam Quim 31:5-8
27. Hussein AA, Barberena I, Capson TL et al (2004) New cytotoxic naphthopyrane derivatives from Adenaria floribunda. J Nat Prod 67:451-453
28. Hussein AA, Barberena I, Correa M et al (2005) Cytotoxic flavonol glycosides from Triplaris cumingiana. J Nat Prod 68:231-233
29. Jackson JBC, Kirby MX, Berger WH et al (2001a) Historical overfishing and the recent collapse of coastal ecosystems. Science 293:629-637
30. Jackson RB, Carpenter SR, Dahm CN et al (2001b) Water in a changing world. Ecol Appl 11:1027-1045
31. Kettler HE, Modi R (2001) Building local research and development capacity for the prevention and cure of neglected diseases: the case of India. Bull World Health Organ 79:742-747
32. Kingston DGI, Abdel-Kader M, Zhou B-N et al (1999) The suriname international cooperative biodiversity group program: lessons from the first five years. Pharm Biol 37(Supplement):22-34
33. Kiss A (2004) Is community-based ecotourism a good use of biodiversity conservation funds? Trends Ecol Evol 19:232-237
34. Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4:206-220
35. Kremen C (2005) Managing ecosystem services: what do we need to know about their ecology? Ecol Lett 8:468-479
36. Kursar TA, Capson TL, Coley PD et al (1999) Ecologically guided bioprospecting in Panama. Pharm Biol 37 (Supplement):114-126
37. Kursar TA, Coley PD (2003) Convergence in defense syndromes of young leaves in tropical rainforests. Biochem Syst Ecol 21:929-949
38. Kursar TA, Caballero-George CC, Capson TL et al (2006) Securing economic benefits and promoting conservation through bioprospecting. BioSci 56:1005-1012
39. Kursar TA, Capson TL, Cubilla-Rios L, et al (2007) Bioprospecting promotes conservation, enhances research capacity and provides economic uses of biodiversity. In: Schnitzler S, Carson W (eds) Tropical forest ecology, Blackwell Scientific (in press)
40. Laird SA, ten Kate K (2002) Linking biodiversity prospecting and forest conservation. In: Pagiola S, Bishop J, Landell-Mills N (eds) Selling forest environmental services. Market-based mechanisms for conservation and development. Sterling, Virginia
41. Linington RG, Gonzalez J, Ureña L-D et al (2007) Venturamides A and B: antimalarial constituents of the Panamanian marine cyanobacterium Oscillatoria sp. J Nat Prod 70:397-401
42. Mani S, Macapinlac M Jr, Goel S et al (2004) The clinical development of new mitotic inhibitors that stabilize the microtubule. Anti-Cancer Drugs 15:553-558
43. McPhail KL, Correa J, Linington RG, et al (2007) Anti-plasmodial linear lipopeptides from a Panama strain of the marine cyanobacterium Lyngbya majuscula. J Nat Prod Web Release Date 19-Apr-2007; DOI: 10.1021/np0700772
44. McShane TO, Wells MP (eds) (2004) Getting biodiversity to work: towards more effective conservation and development. Colombia University Press, New York, NY
45. Montenegro H, Gutiérrez M, Romero LI et al (2003) Aporphine alkaloids from Guatteria spp. with leishmanicidal activity. Planta Med 69:677-679
46. Morel CM, Acharya T, Broun D et al (2005) Health innovation networks to help developing countries address neglected diseases. Science 309:401-404
47. Myers N, Kent J (2003) New consumers: The influence of affluence on the environment. Proc Natl Acad Sci USA 100:4963-4968
48. Neto RB, Dickson D (1999) $3m deal launches major hunt for drug leads in Brazil. Nature 400:302
49. Newman DJ, Cragg GM, Snader KM et al (2003) Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66:1022-1037
50. Newmark WD, Hough JL (2000) Conserving wildlife in Africa: integrated conservation and development projects and beyond. BioScience 50:585-592
51. Odling-Smee L (2005) Conservation: dollars and sense. Nature 437:614-616
52. Ortega-Barría E, Corbett Y, Herrera L et al (2005) Fluorescence-based bioassay for anti-parasitic drugs. In: Patent US (ed) International application published under the Patent Cooperation Treaty (PCT)
53. Ospina CA, Rodriguez AD, Sanchez JA et al (2005) Caucanolides A-F, unusual antiplasmodial constituents from a Colombian collection of the gorgonian coral Pseudopterogorgia bipinnata. J Nat Prod 68:1519-1526
54. Paterson I, Anderson EA (2005) The renaissance of natural products as drug candidates. Science 310:451-453
55. Pauly D, Christensen V, Guénette S et al (2002) Towards sustainability in world fisheries. Nature 418:689-695
56. Plucknett DL, Smith NJH, Williams JT, Anishetty NM (1987) Gene banks and the world's food. Princeton University Press, Princeton, New Jersey
57. Rabalais NN, Turner RE, Wiseman Jr WJ (2002) Gulf of Mexico hypoxia, a.k.a. The Dead Zone. Annu Rev Ecol Syst 33:235-263
58. Ramankutty N, Foley JA (1999) Estimating historical changes in land cover: North American croplands from 1850 to 1992. Global Ecol Biogeog 8:381-396
59. Reid WV (2004) Bridging the science - Policy divide. PLoS Biol 2:169-171
60. Rosen MK, Schreiber SL (1992) Natural products as probes of cellular function: studies of immunophilins. Angew Chem Int Ed Engl 31:384-400
61. Rosenthal JP, Beck D, Bhat A et al (1999) Combining high-risk science with ambitious social and economic goals. Pharm Biol 37(Supplement):6-21
62. Rosenthal JP, Katz FN (2004) Natural products research partnerships with multiple objectives in global biodiversity hotspots: Nine years of the International Cooperative Biodiversity Groups Program. In: Bull A (ed) Microbial diversity and bioprospecting. ASM Press, Washington DC, pp 458-466
63. Sachs JD, Reid WV (2006) Investments toward sustainable development. Science 312:1002
64. Schuster BG, Jackson JE, Obijiofor CN et al (1999) Drug development and conservation of biodiversity in West and Central Africa: A model for collaboration with indigenous people. Pharm Biol 37(Supplement):84-99
65. Schwartzman S, Moreira A, Nepstad D (2000) Rethinking tropical forest conservation: perils in parks. Conserv Biol 14:1351-1357
66. Simmons TL, McPhail KL, Ortega-Barría E et al (2006) Belamide A, a new antimitotic tetrapeptide from a Panama marine cyanobacterium. Tetrahedron Lett 47:3387-3390
67. Soejarto DD, Gyllenhaal C, Regalado JC et al (1999) Studies on biodiversity of Vietnam and Laos: The UIC-based ICBG program. Pharm Biol 37(Supplement):100-113
68. tenKate K, Laird SA (1999) The commercial use of biodiversity: access to genetic resources and benefit-sharing. Earthscan Publications Ltd., London
69. Tilman D, Fargione J, Wolff B et al (2001) Forecasting agriculturally driven global environmental change. Science 292:281-284
70. Torres-Mendoza D, Ureña-González LD, Ortega-Barría E et al (2003) Five new cassane diterpenes from Myrospermum frutescens with activity against Trypanosoma cruzi. J Nat Prod 66:928-932
71. Torres-Mendoza D, Ureña-González LD, Ortega-Barría E et al (2004) Novel cassane and cleistanthane diterpenes from Myrospermum frutescens: Absolute stereochemistry of the cassane diterpene series. J Nat Prod 67:1711-1715
72. Trouiller P. Torreele E, Olliaro P et al (2001) Drugs for neglected diseases: a failure of the market and a public policy health failure? Trop Med Int Health 6:945-951
73. UNCTAD (2005) World investment report 2005. Transnational corporations and the internationalization of R & D. In: United Nations conference on trade and development (UNCTAD) United Nations, New York and Geneva
74. United Nations (2004) World urbanization prospects: the 2003 revision. Table A.2. http://www.un.org/esa/population/publications/wup2003/WUP2003.htm. Cited 18 April 2007
75. Wei X, Rodríguez A, Baran P et al (2004) Antiplasmodial cembradiene diterpenoids from a southwestern Caribbean gorgonian octocoral of the genus Eunicea. Tetrahedron Lett 60:11813-11819
76. Williams C, Espinosa OA, Montenegro H et al (2003) Hydrosoluble formazan XTT: its application to natural products drug discovery for Leishmania. J Microbiol Methods 55:813-816
77. Willis RC (2006) e-Therapeutics takes the road to Rio. Drug Discov News December, 25-28